Facilitating lifestyle changes to manage menopausal symptoms in women with breast cancer: A randomized controlled pilot trial of The Pink Women's Wellness Program

Menopause

Volumn 22, Issue 9, 2015, Pages 937-945

  Anderson, Debra J ^a   Seib, Charrlotte ^a   Mccarthy, Alexandra L ^a,b   Yates, Patsy ^a   Porter Steele, Janine ^c   Mcguire, Amanda ^a   Young, Leonie ^c  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c Kim Walters Choices Program   (Australia)

Author keywords

Breast neoplasms; Lifestyle risk reduction; Menopause; Randomized controlled trial; The Pink Women's Wellness Program

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CLINICAL ASSESSMENT TOOL; CONSULTATION; CONTROLLED STUDY; FEMALE; FOOD INTAKE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY BREAST SUBSCALE SCORE; GREENE CLIMACTERIC SCALE; HEALTH EDUCATION; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICAL RESEARCH; MENOPAUSE; MIDDLE AGED; PHYSICAL ACTIVITY; PILOT STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SHORT FORM 12; SLEEP DISORDER; SMOKING; VASOMOTOR DISORDER; WELLBEING; BREAST TUMOR; HEALTH BEHAVIOR; LIFESTYLE; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

BREAST NEOPLASMS; FEMALE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MENOPAUSE; MIDDLE AGED; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84956774759     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000421     Document Type: Article

References (73)

1. Australian Institute of Health and Welfare (AIHW) in association with Cancer Australia and the Australian Association of Cancer Registries. Cancer Survival and Prevalence in Australia: Cancers Diagnosed From 1982 to 2004. Canberra, Australia: Australian Institute of Health and Welfare 2008
2. Cancer Research UK. Cancer stats-cancer statistics for the UK. Available at: http://info.cancerresearchuk.org/cancerstats/. Accessed January 11, 2014
3. Anderson DJ, Yoshizawa T, Gollschewski S, et al. Menopause in Australia and Japan: effects of country of residence on menopausal status and menopausal symptoms. Climacteric 2004; 7: 165-174
4. Gupta P, Sturdee DW, Palin SL, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 2006; 9: 49-58
5. Mar Fan HG, Houede-Tchen N, Chemerynsky I, et al. Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study. Ann Oncol 2010; 21: 983-987
6. Crandall C, Petersen L, Ganz PA, et al. Association of breast cancer and its therapy with menopause-related symptoms. Menopause 2004; 11: 519-530
7. Conde DM, Pinto-Neto AM, Cabello C, et al. Menopause symptoms and quality of life in women aged 45 to 65 years with and without breast cancer. Menopause 2005; 12: 436-443
8. Col N, Kim J, Chlebowski R. Menopause hormone therapy after breast cancer: a meta-Analysis and critical appraisal of the evidence. Breast Cancer Res 2005; 7: R535-R540
9. Greiser C, Greiser E, Dören M. Menopausal hormone therapy and risk of breast cancer: a meta-Analysis of epidemiological studies and randomized controlled trials. Hum Reprod Update 2005; 11: 561-573
10. Shah NR, Borenstein J, Dubois RW. Postmenopausal hormone therapy and breast cancer: a systematic review and meta-Analysis. Menopause 2005; 12: 668-678
11. Gainford M, Simmons C, Nguyen H, et al. A practical guide to the management of menopausal symptoms on breast cancer patients. Support Care Cancer 2005; 13: 573-578
12. Melby MK, Anderson D, Sievert LL, et al. Methods used in cross-cultural comparisons of vasomotor symptoms and their determinants. Maturitas 2011; 70: 110-119
13. Thurston RC, Sowers MFR, Chang Y, et al. Adiposity and reporting of vasomotor symptoms among midlife women: the Study of Women's Health Across the Nation. Am J Epidemiol 2008; 167: 78-85
14. Appling S, Paez K, Allen J. Ethnicity and vasomotor symptoms in postmenopausal women. J Womens Health 2007; 16: 1130-1138
15. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation. Am J Public Health 2006; 96: 1226-1235
16. Im E-O, Lee B, Chee W, et al. Menopausal symptoms among four major ethnic groups in the United States. West J Nurs Res 2010; 32: 540-565
17. Green R, Santoro N. Menopausal symptoms and ethnicity: the Study of Women's Health Across the Nation. Womens Health 2009; 5: 127-133
18. Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 2004; 159: 1189-1199
19. Greendale GA, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 2005; 118: S148-S154
20. WhitemanMK, StaropoliCA, Langenberg PW, et al. Smoking, bodymass, and hot flashes in midlife women. Obstet Gynecol 2003; 101: 264-272
21. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000; 152: 463-473
22. Crawford SL, Avis NE, Gold E, et al. Sensitivity and specificity of recalled vasomotor symptoms in a multiethnic cohort. Am J Epidemiol 2008; 168: 1452-1459
23. Whiteman MK, Staropoli CA, Benedict JC, et al. Risk factors for hot flashes in midlife women. J Womens Health 2003; 12: 459-472
24. Staropoli CA, Flaws JA, Bush TL, et al. Predictors of menopausal hot flashes. J Womens Health 1998; 7: 1149-1155
25. Sabia S, Fournier A, Mesrine S, et al. Risk factors for onset of menopausal symptoms: results from a large cohort study. Maturitas 2008; 60: 108-121
26. Freeman EW, Sammel MD, Grisso JA, et al. Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women. J Womens Health Gend Based Med 2001; 10: 67-76
27. Di Donato P, Giulini NA, Bacchi Modena A, et al. Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas 2005; 52: 181-189
28. Li C, Samsioe G, Borgfeldt C, et al. Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (The Women's Health in Lund Area study). Am J Obstet Gynecol 2003; 189: 1646-1653
29. Moilanen J, Aalto AM, Hemminki E, et al. Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-Aged women. Maturitas 2010; 67: 368-374
30. Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women's Health Across the Nation. Obstet Gynecol Clin North Am 2011; 38: 489-501
31. Nelson DB, Sammel MD, Freeman EW, et al. Effect of physical activity on menopausal symptoms among urban women. Med Sci Sports Exerc 2008; 40: 50-58
32. Greene JG. Constructing a standard climacteric scale. Maturitas 1998; 29: 25-31
33. Bandura A. Health promotion by social cognitive means. Health Educ Behav 2004; 31: 143-164
34. Lorig KR, Ritter PL, Laurent DD, et al. Internet-based chronic disease self-management: a randomized trial. Med Care 2006; 44: 964-971
35. Roach JB, Yadrick MK, Johnson JT, et al. Using self-efficacy to predict weight loss among young adults. J Am Diet Assoc 2003; 103: 1357-1359
36. Mancuso CA, Rincon M, McCulloch CE, et al. Self-efficacy, depressive symptoms, and patients' expectations predict outcomes in asthma. Med Care 2001; 39: 1326-1338
37. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-379
38. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401
39. Lee KA. Self-reported sleep disturbances in employed women. Sleep 1992; 15: 493-498
40. Waltman N, Twiss J, Ott C, et al. Testing an intervention for preventing osteoporosis in postmenopausal breast cancer survivors. J Nurs Scholarsh 2003; 35: 333-337
41. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multi-dimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191-208
42. Ryan P, Lauver R. The efficacy of tailored interventions. Image 2002; 34: 331-337
43. Craig CL, Marshall AL, Sjöström M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 1381-1395
44. Giles GG, Ireland PD. DietaryQuestionnaire for Epidemiological Studies (Version 2). Melbourne, Australia: The Cancer Council Victoria; 1996
45. Hodge A, Giles GG, Patterson A, et al. The Anti-Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with diet diaries in young and middle-Aged women in a study of iron supplementation. Aust N Z J Public Health 2000; 24: 576-583
46. National Health and Medical Research Council. Hormone Replacement Therapy: A Summary of the Evidence for General Practitioners and Other Health Professionals. Canberra, Australia: National Health and Medical Research Council; 2005
47. Bandura A. Self-Efficacy: The Exercise of Control. New York, NY: WH Freeman; 1997
48. National Breast and Ovarian Cancer Centre. Breast Cancer and Early Menopause-A Guide for Younger Women. Surry Hills, NSW: National Breast and Ovarian Cancer Centre; 2008
49. National Breast Cancer Centre and the National Cancer Control Initiative. Clinical Practice Guidelines for the Psychosocial Care of Adults With Cancer. Camperdown, NSW: National Breast Cancer Centre; 2003
50. Yates P, Aranda S, Hargraves M, et al. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 2005; 23: 6027-6036
51. World Cancer Research Fund/American Institute for Cancer Research. Continuous Project Report Summary. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer. Washington, DC: World Cancer Research Fund/American Institute for Cancer Research; 2010
52. Anderson DJ, Lang CP. The Pink Women's Wellness Program Journal: Wellness After Breast Cancer. A 12-Week Companion to The Pink Women's Wellness Program Book. Brisbane, Australia: Queensland University of Technology; 2010
53. Anderson DJ, Graham V. The Pink Women's Wellness Program Book. Brisbane, Australia: Queensland University of Technology; 2011
54. National Breast and Ovarian Cancer Centre. Guide for Women With Early Breast Cancer. Surry Hills, NSW: National Breast and Ovarian Cancer Centre; 2008
55. Brady M, Cella D, Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality of life instrument. J Clin Oncol 1997; 15: 974-986
56. Ware J, Kosinski M, Keller S. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233
57. Cancer Council Victoria. Dietary Questionnaire for Epidemiological Studies (DQES v2): User Information Guide. Carlton, VIC: Cancer Council Victoria; 2009
58. Buysse D, Reynolds C, Monk T, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213
59. Bandura A. The primacy of self-regulation in health promotion. Appl Psychol 2005; 54: 245-254
60. Greene JG. Factor Analyses of Climacteric Symptoms: Toward a Consensual Measure. Glasgow, UK: Department of Psychological Medicine, University of Glasgow; 1990
61. Ware J, Sherbourne C. The MOS 36-Item Short-Form Health Survey (SF-36), 1: conceptual framework and item selection. Med Care 1992; 30: 473-483
62. World Health Organisation (WHO). Global Strategy on Diet, Physical Activity and Health. Geneva, Switzerland: WHO; 2004
63. World Health Organisation (WHO). Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva, Switzerland: WHO; 2000
64. Statistical Package for the Social Sciences (Version 19.0). Chicago, IL: SPSS Inc; 2010
65. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27: S178-S189
66. Cohen J. Statistical Power Analysis for the Behavioral Science. Hillsdale, NJ: Lawrence Erlbaum Associates Inc; 1988
67. Bardwell WA, Major JM, Rock CL, et al. Health-related quality of life in women previously treated for early-stage breast cancer. Psychooncology 2003; 13: 595-604
68. McPhail G, Smith LN. Acute menopause symptoms during adjuvant systemic treatment for breast cancer: a case-control study. Cancer Nurs 2000; 23: 430-443
69. Rogers M, Kristjanson LJ. The impact on sexual functioning of chemotherapy-induced menopause in women with breast cancer. Cancer Nurs 2002; 25: 57-65
70. Coe R. It's the effect size, stupid: what effect size is and why it is important. Paper presented at: Annual Conference of the British Educational Research Association; September 12-14, 2002; Exeter, England. Available at: http://www.leeds.ac.uk/educol/documents/00002182.htm. Accessed July 1, 2013
71. Sullivan GM, Feinn R. Using effect size-or why the P value is not enough. J Grad Med Educ 2012; 4: 279-282
72. National Institute of Clinical Excellence (NICE). Depression: Management of Depression in Primary and Secondary Care. Clinical Practice Guideline No. 23. London, England: National Institute for Clinical Excellence; 2004
73. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003; 1: 79